This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shanghai Institute of Biological Products Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Jin Lu - Innovator in Monoclonal Antibody Development
Introduction
Jin Lu is a prominent inventor based in Shanghai, China. He is known for his significant contributions to the field of biotechnology, particularly in the development of humanized monoclonal antibodies. His work has the potential to impact the treatment of various diseases related to the HER3 antigen.
Latest Patents
Jin Lu holds a patent for an anti-HER3 humanized monoclonal antibody. This innovative antibody is designed to bind to the HER3 antigen, demonstrating high affinity and biological activity while maintaining low immunogenicity. Its structural stability makes it a promising candidate for drug development aimed at preventing or treating HER3-related diseases.
Career Highlights
Jin Lu is affiliated with the Shanghai Institute of Biological Products Co., Ltd., where he has been instrumental in advancing research and development in monoclonal antibody therapies. His expertise in this area has positioned him as a key figure in the biotechnology sector.
Collaborations
Jin Lu has collaborated with notable colleagues, including Aidong Qu and Hongyuan Liang. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Jin Lu's work in developing the anti-HER3 humanized monoclonal antibody exemplifies his commitment to advancing medical science. His contributions are paving the way for new therapeutic options in the treatment of HER3-related diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile